Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. Stock
Equities
RMDA
EGS381B1C015
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.06 EGP | -4.19% | -17.93% | +24.85% |
Sales 2024 * | 2.92B 60.85M | Sales 2025 * | 3.21B 67.01M | Capitalization | 3.07B 64.04M |
---|---|---|---|---|---|
Net income 2024 * | 361M 7.53M | Net income 2025 * | 485M 10.11M | EV / Sales 2024 * | 1.42 x |
Net Debt 2024 * | 1.07B 22.25M | Net Debt 2025 * | 766M 15.98M | EV / Sales 2025 * | 1.19 x |
P/E ratio 2024 * |
6.93
x | P/E ratio 2025 * |
6.31
x | Employees | - |
Yield 2024 * |
3.42% | Yield 2025 * |
5.16% | Free-Float | 50.28% |
1 day | -4.19% | ||
1 week | -17.93% | ||
Current month | -20.77% | ||
1 month | -23.70% | ||
3 months | +3.00% | ||
6 months | +29.56% | ||
Current year | +24.85% |
Managers | Title | Age | Since |
---|---|---|---|
Amr Morsy
CEO | Chief Executive Officer | - | 10-12-31 |
Mahmoud Fayek
DFI | Director of Finance/CFO | - | 18-12-31 |
Rania Farouk
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Farida Khamis
BRD | Director/Board Member | - | 19-12-31 |
Director/Board Member | 65 | 18-12-31 | |
Director/Board Member | - | 10-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 2.06 | -.--% | 3,548,009 |
24-04-30 | 2.06 | -4.19% | 7,846,718 |
24-04-29 | 2.15 | +0.47% | 4,220,854 |
24-04-28 | 2.14 | -3.60% | 9,835,275 |
24-04-24 | 2.22 | -6.33% | 13,400,680 |
End-of-day quote Egyptian Exchange, April 29, 2024
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+24.85% | 64.17M | |
+33.25% | 699B | |
+25.87% | 571B | |
-3.55% | 364B | |
+18.16% | 326B | |
+4.36% | 286B | |
+14.79% | 236B | |
+4.94% | 198B | |
-10.18% | 194B | |
-3.69% | 149B |
- Stock Market
- Equities
- RMDA Stock